Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
Persistent IBD flares often result from incomplete or lost response to medication, microscopic inflammation, suboptimal dosing, or overlapping conditions, and clinical trials can offer access to cutting edge therapies, close specialist monitoring, and the possibility of better disease control.
There are several factors to consider. See below for the exact tests to confirm inflammation, how to optimize current therapy and address nutrition, stress, and sleep, urgent red flags to act on, and the questions to ask your doctor about emerging options and whether an IBD clinical trial is right for you.
If you're living with inflammatory bowel disease (IBD) and still experiencing flares despite treatment, you are not alone. Many people with Crohn's disease or ulcerative colitis continue to struggle with symptoms even while taking prescribed medications. Ongoing inflammation can feel frustrating, confusing, and discouraging — especially when you're doing "everything right."
The good news? Treatment options are expanding rapidly. Research continues to uncover why some patients don't respond fully to current therapies, and IBD clinical trial benefits are opening doors to new possibilities for healing.
Let's break down why your gut may not be healing — and what you can do next.
IBD is complex. It's not just "gut irritation." It's a chronic immune condition where the body mistakenly attacks the digestive tract. Even when symptoms improve, inflammation can still be present at a microscopic level.
Here are common reasons flares may continue:
Biologics, immunomodulators, aminosalicylates, and steroids can be highly effective — but not for everyone. Up to one-third of patients may not respond to their first biologic therapy, according to large clinical studies. Others lose response over time.
You might feel "better," but colonoscopy or stool tests (like fecal calprotectin) may show inflammation. Healing symptoms and healing tissue are not always the same thing.
Drug levels may be too low to control inflammation. Therapeutic drug monitoring can sometimes identify whether adjusting dosage could help.
IBS, infections, bile acid malabsorption, or small intestinal bacterial overgrowth (SIBO) can mimic IBD flares.
Stress, smoking (especially in Crohn's disease), poor sleep, and inconsistent medication use can worsen inflammation.
IBD is not something to ignore. While you don't need to panic, persistent symptoms deserve medical attention.
Speak to a doctor urgently if you experience:
These could signal complications such as severe inflammation, obstruction, or infection.
If you're experiencing concerning symptoms and want to better understand whether they align with Ulcerative Colitis, a free AI-powered symptom checker can help you prepare for a more informed conversation with your doctor.
Medical research in IBD is advancing faster than ever. New biologics, small-molecule drugs, microbiome therapies, and precision medicine approaches are in development.
Participating in research may offer meaningful IBD clinical trial benefits, especially for patients who are not responding to standard treatments.
Clinical trials are carefully monitored research studies that test new treatments, new drug combinations, or new ways of using existing therapies. They must follow strict safety and ethical guidelines.
Before approval, every medication goes through multiple phases of testing to evaluate:
For some patients, clinical trials provide more than just access to new medication. Benefits may include:
You may receive a medication that is not yet available to the public — including next-generation biologics or oral targeted therapies.
Participants are typically followed closely by specialists, with regular labs, imaging, and symptom tracking.
Your participation may help improve care for millions of people with IBD worldwide.
Some patients experience significant improvement after switching to investigational therapies — particularly if they've failed other medications.
Safety is a top priority. Trials must be approved by institutional review boards (IRBs) and follow federal regulations. Participants are informed of potential risks before enrolling.
That said, no treatment — including approved medications — is risk-free. A conversation with your gastroenterologist is essential before considering participation.
Whether or not you pursue clinical trial options, there are evidence-based steps that can support healing.
Before changing treatment, confirm whether inflammation is present. This may include:
Treating symptoms without confirming inflammation can lead to unnecessary medication changes.
Sometimes the solution isn't switching drugs — it's adjusting them.
Discuss with your doctor:
Malnutrition is common in IBD, even in people who appear to eat normally.
Consider:
Diet alone does not cure IBD, but proper nutrition supports healing.
The gut and brain are deeply connected. Chronic stress can worsen symptoms and increase flare risk.
Helpful strategies include:
These do not replace medication but can improve overall disease control.
Beyond biologics, newer treatments being studied include:
Many of these advances are being evaluated in clinical trials, highlighting additional IBD clinical trial benefits for eligible patients.
One important truth: IBD healing is often slow. Mucosal healing — actual repair of the gut lining — can take months. It's not unusual to require multiple treatment adjustments before finding the right fit.
This does not mean you've failed.
It means your disease is unique.
If you're still flaring, bring these questions to your next appointment:
Having a structured discussion can help you feel more in control.
It's important not to ignore persistent inflammation. Untreated IBD can lead to complications such as strictures, fistulas, hospitalization, or increased colon cancer risk in long-standing disease.
But it's equally important not to panic.
Treatment options today are far more advanced than they were even ten years ago. Many patients who once required surgery now achieve long-term remission with newer therapies.
Exploring IBD clinical trial benefits may be one part of your journey — but it's not the only path. Optimizing current care, addressing nutrition and stress, and working closely with a gastroenterologist remain foundational steps.
If your gut isn't healing:
Most importantly, speak to a doctor about ongoing or worsening symptoms — especially if they involve severe pain, bleeding, fever, or dehydration. Early action prevents complications.
IBD can be unpredictable, but it is treatable. With the right strategy — and sometimes new research-driven options — healing is possible.
(References)
* Neurath MF. Advances in therapy for inflammatory bowel disease. J Intern Med. 2023 Mar;293(3):286-302. doi: 10.1111/joim.13576. PMID: 36471813.
* Kopylov U. Personalized Medicine in Inflammatory Bowel Disease: Moving Towards a Precision-Based Approach. J Clin Med. 2023 Mar 15;12(6):2274. doi: 10.3390/jcm12062274. PMID: 36983377; PMCID: PMC10053915.
* Parian AM, Alkhayyat M, Shah SC. Biomarkers in Inflammatory Bowel Disease: A Review of Current and Future Clinical Applications. Curr Gastroenterol Rep. 2022 Nov;24(11):310-318. doi: 10.1007/s11894-022-00859-9. PMID: 36329064.
* Khanna R, Limdi JK, Sood A, et al. Management of refractory inflammatory bowel disease. Aliment Pharmacol Ther. 2021 May;53(9):965-979. doi: 10.1111/apt.16335. PMID: 33749876.
* D'Haens GR, Danese S, Taylor SA, et al. Mucosal Healing in Inflammatory Bowel Disease: From Clinical Trials to Real-World Evidence. Dig Dis Sci. 2020 Dec;65(12):3526-3535. doi: 10.1007/s10620-020-06649-1. PMID: 33107056.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.